Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Original Article
Author Details :
Volume : 1, Issue : 3, Year : 2016
Article Page : 86-91
Abstract
Introduction: KRAS mutation occurs in colorectal cancers in about 35%-45% cases. Colorectal carcinoma develops from precursor lesions and KRAS mutations occur early in carcinogenesis. KRAS mutation status can help to predict the course and also determine optimal adjuvant therapy.
Aims and Objectives: To detect the presence of KRAS mutations in the deoxyribonucleic acid (DNA) isolated from tissue of colorectal carcinomas and precursor lesions and infer the rate of positivity and negativity of these mutations and correlate them with the type and grade of lesion.
Materials and Methods: This was a retrospective hospital based study done in three years (2009 to 2012) at MGM Hospital, Warangal. Tissue from precancerous lesions and diagnosed cases of colorectal carcinomas was studied for histopathology; and for KRAS mutation by PCR-SSCP.
Observations and Results: On histopathology, there were 35 cases of adenocarcinomas, 21 (60%) being well differentiated, 9 (25.7%) and 3 (8.5%) being moderate and poorly differentiated and 2 cases (5.7%) being mucinous carcinoma. PCR-SSCP was performed on 32 cases. 9 cases (33.3% adenomatous polyps and 38% adenocarcinomas) were positive. The KRAS mutation positivity was 50% for poorly differentiated colorectal adenocarcinoma and was 33% each for both well and moderately differentiated adenocarcinoma.
Conclusion: In our study, 38% of colorectal adenocarcinomas and 33.3% of adenomatous adenomas were positive for KRAS mutation. As KRAS has a role in adenoma-carcinoma sequence, and also considering the treatment aspects, we recommend KRAS mutation study for above lesions.
Keywords: Adenomatous polyps, Colorectal adenocarcinomas, KRAS mutation, PCR-SSCP
How to cite : Anitha S, Kanyakumari, Durga K, Significance and Incidence of KRAS Mutations in Colorectal Carcinoma and Precancerous Lesions-A Retrospective Study in a Tertiary Care Centre. IP Arch Cytol Histopathol Res 2016;1(3):86-91
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.